Which statement is NOT true of EFAD in patients with cystic fibrosis?

• A. Biochemical EFAD may be seen in both pancreatic sufficient and insufficient patients
• B. Routine supplementation of omega-3 fatty acids is essential in the management of CF
• C. Those patients with moderate to severe lung disease are at high risk for EFAD
• D. Poor growth and pulmonary status correlate with biochemical markers of EFAD

Answer: (B)